In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...] Read More »
Category: Providers
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Six national hospital associations recently urged the Supreme Court to correct what they called the Department of Health and Human [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal court last week sided with a group of Texas hospitals’ efforts to block—at least temporarily—a Department of Health [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...] Read More »